SLIDE 1
Consultant Transplant & Access Surgeon
‘The HeRO Graft’
An option for patients with End Stage Vascular Access
SLIDE 2
Disclosures
I have the following potential conflicts of interest to report:
I currently hold a consultancy contract with Merit Medical and am paid for any work undertaken. I have received Honoraria from Getinge Maquet
SLIDE 3
- Good Pump Speeds
- Normal Pressures
- Process good volumes
- Excellent Adequacy
SLIDE 4
SLIDE 5 Consuming the ‘venous capital’
RRT journey
- 2 or more lines (tunneled)
- 3 or more fistulae
- AV Graft(s)
- 1-2 Transplants
An increasing access challenge Especially if develop CVS / CVO
SLIDE 6 End Stage Vascular Access
‘End stage access is reached when all autologous vein
- ptions and conventional graft and catheter placements
have been exhausted or are not possible and there is the presence of central vein pathology’ (Gilbert VASBI 2014)
SLIDE 7
SLIDE 8
SLIDE 9
SLIDE 10
Venous Hypertension
SLIDE 11 What could we do?
Leave them on a line (wherever we can place one) Consider a ‘Heroic Intervention’
Any procedure or intervention that seeks to treat or bypass Central Venous Pathology (CVP) to enable:
- Autologous access or grafts to function
- Treatment / prevention of venous hypertension
SLIDE 12
Heroic Options:
Use of Lower Limbs Angioplasty / Stenting CVS Atypical / Exotic access / bypass procedures HeRO graft Insertion Surfacer Inside Out Catheter System
SLIDE 13
Hemodialysis Reliable Outflow (HeRO)
▪ Treatment option for ESVA patients ▪ Only fully subcutaneous AV access option that offers long term access in CVS ▪ Option for patients with failing AVF or graft due to CVS ▪ Option for the catheter dependent or approaching catheter dependence patient with CVS
SLIDE 14
HeRO is a 2 Component Device
SLIDE 15
Venous Outflow Component
Braided Nitinol stent Covered with Silicon
“HeRO is a Customizable, Sizeable REMOVABLE stent”
Kink Resistant Crush Resistant
SLIDE 16
Arterial Graft Component Venous Outflow Component
SLIDE 17
SLIDE 18
SLIDE 19
SLIDE 20
SLIDE 21
SLIDE 22
SLIDE 23 3 TCC’s in 3 years!
- 3 AVF attempts, Right B/C AVF eventually successful
- 18 months venous hypertension (arm, face, tongue, vocal cords!)
- Home Haemo patient, agrophobia, wants to stay that way!
SLIDE 24
- Left IJ HeRO
- Necklaced across to right side
- Joined onto Right B/C AVF
- Maintained needling areas
- Instant symptom relief
SLIDE 25
SLIDE 26
SLIDE 27
SLIDE 28
SLIDE 29
SLIDE 30
SLIDE 31
SLIDE 32
SLIDE 33
SLIDE 34
SLIDE 35
SLIDE 36 Clinical Outcomes
HeRO Graft
Oxford
NA 84.6 % 1.125
SLIDE 37
SLIDE 38
- Super HeRO Adaptor first product of its kind in vascular surgery
- Coupling device that allows for certain grafts to be used with
HeRO Outflow Component
- Avoids graft to graft anastomosis
Adapter
Make your own with Super HeRO
SLIDE 39
SLIDE 40
SLIDE 41 Closing Comments
ESVA patients increasingly more common Any history / presence of a TCC accelerates ESVA due to Central
Vein Stenosis / Occlusion
The HeRO Graft is the only AV access option that can bypass
CVS and provide reliable dialysis
The Super HeRO adaptor enables direct connection of certain
grafts with the outflow and avoids a graft – graft anastomosis or bridging catheter
SLIDE 42
james.gilbert@ouh.nhs.uk